Truist raised the firm’s price target on Amwell (AMWL) to $12 from $10 and keeps a Hold rating on the shares. The firm is citing improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback